Alps Advisors Inc Immutep LTD Transaction History

Alps Advisors Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$1.96 - $3.09 $174,639 - $275,325	-89,102 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.3 - $3.61 $30,410 - $47,731	-13,222 Reduced 12.92%	89,102 $244,000
Q4 2021 Feb 09, 2022	BUY	$3.09 - $4.81 $7,474 - $11,635	2,419 Added 2.42%	102,324 $336,000
Q3 2021 Nov 15, 2021	BUY	$3.17 - $4.39 $155,028 - $214,692	48,905 Added 95.89%	99,905 $387,000
Q2 2021 Aug 11, 2021	BUY	$3.02 - $5.21 $154,020 - $265,710	51,000 New	51,000 $197,000

2.41M

526K

222K

Ticker IMMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,000
Market Cap $172M
Description
Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.